Important Deadlines for Ottawa NMD 2023
The Ottawa International Conference on Neuromuscular Disease and Biology (Ottawa NMD 2023) deadline for discounted early-bird registration and abstract submission is June 30th!
The Ottawa NMD 2023 Conference will feature top international basic and clinical neuromuscular (NMD) researchers highlighting advances in neuromuscular disease research and clinical care, including novel diagnostic techniques, disease pathogenesis, basic muscle and stem cell biology, and promising therapies to treat these devastating disorders. Sessions will be organized to include basic, translational and clinical presentations to engage all attendees, regardless of background or training. New for this year are more clinical sessions and Continuing Medical Education (CME) credits!
Please visit the Ottawa NMD 2023 website for the latest information about the conference including updates to the confirmed speaker list.
NMD4C Annual Meeting to Take Place Directly Before Ottawa NMD 2023
The NMD4C Annual Meeting will take place in Ottawa during the day on Thursday September 7th before Ottawa NMD 2023 begins. The NMD4C meeting will be an opportunity to share your input on the network’s future activities, discuss emerging topics in NMDs, recognize NMD4C early-career awardees and funding recipients, and network with Canadian neuromuscular clinicians and researchers. Don’t miss this opportunity to attend both events! More information on the NMD4C Annual Meeting is available here.
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.